| Peer-Reviewed

Evaluation of Uric Acid and Its Correlation with Decline in Estimated Glomerular Filtration Rate among the Chronic Kidney Disease Patients

Received: 5 December 2022    Accepted: 16 January 2023    Published: 31 January 2023
Views:       Downloads:
Abstract

Chronic kidney disease is one of the most serious public health burdens globally, with significant morbidity, mortality, and compromise patient life expectancy. Many sub-Saharan African countries face double-burden challenges in the treating of chronic kidney disease and its associated complications. The current study aims to evaluate serum uric acid, and its correlation with estimated glomerular filtration rate as well as other risk factors among the chronic kidney disease patients on follow-up at renal clinic of Jimma University specialized referral hospital. An Institution-based cross-sectional study was conducted at Jimma University referral from August 6, 2022, to November 13, 2022. A consecutive sampling technique was employed to recruit the study participants into the current study. Data were collected using interviewer-based structured questionnaires and patient’s record reviews. The collected data were analyzed by SPSS version 25.0. Pearson’s correlation analyses was used to check the correlation between estimated glomerular filtration rate and uric acid. Univariate and multivariate linear regression model was used to test predictors of serum uric acid in the study participants. The total study participants were 140 individuals. Subjects included (54.3% [n=76]) men and (45.7% [n=64]) women, respectively. The mean (SD) age of study subjects was 51.04±9.02 years. The mean value of serum uric acid was 7.2±2.1mg/dl whereas the mean of estimated glomerular filtration rate (eGFR) was 54.2±31 mL/min/1.73m2. Furthermore, the mean values of serum creatinine and blood urea nitrogen among participants in this study were 3.2±1.4 and 67.8±35.8 mg/dL respectively. In the current study, estimated glomerular filtration rate (eGFR) value was negatively correlated (r=-0.912, P<0.001) with uric acid. However, systolic blood pressure was positively correlated (r=0.584, P<0.001) with uric acid. Moreover, the eGFR value was negatively associated (β=-0.060, P=<0.001) with uric acid among study participants. Based on the current study finding, an increase in serum uric acid was associated with a decrease in eGFR value. Increased serum uric acid, increased body mass index and high blood pressure are independent risk factors for disease progression in patients with CKD.

Published in European Journal of Clinical and Biomedical Sciences (Volume 8, Issue 6)
DOI 10.11648/j.ejcbs.20220806.12
Page(s) 84-91
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Serum Uric Acid, Chronic Kidney Disease, Body Mass Index, Estimated Glomerular Filtration Rate

References
[1] I. I. Ulasi and C. K. Ijoma, “The enormity of chronic kidney disease in Nigeria: The situation in a teaching hospital in south-east Nigeria,” J. Trop. Med., no. May 2014, 2010, doi: 10.1155/2010/501957.
[2] A. S. Levey et al., “Chronic kidney disease as a global public health problem: Approaches and initiatives - A position statement from Kidney Disease Improving Global Outcomes,” Kidney Int., vol. 72, no. 3, pp. 247–259, 2007, doi: 10.1038/sj.ki.5002343.
[3] A. Niang and A. T. Lemrabott, “Global Dialysis Perspective: Senegal,” Kidney360, vol. 1, no. 6, pp. 538–540, 2020, doi: 10.34067/kid.0000882020.
[4] G. Tomaiuolo, “Biomechanical properties of red blood cells in health and disease,” Biomicrofluidics, vol. 8, no. 5, pp. 1–19, 2014, doi: 10.1063/1.4895755.
[5] M. C. Thomas, M. E. Cooper, and P. Zimmet, “Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease,” Nat. Publ. Gr., vol. 12, no. 2, pp. 73–81, 2015, doi: 10.1038/nrneph.2015.173.
[6] D. E. Stec, P. A. Hosick, and P. Joey, “Bilirubin, renal hemodynamics, and blood pressure,” vol. 3, no. February, pp. 1–7, 2012, doi: 10.3389/fphar.2012.00018.
[7] P. Caleb, J. Lima, J. E. Krieger, and A. C. Pereira, “Renin – Angiotensin System, Hypertension, and Chronic Kidney Disease : Pharmacogenetic Implications Angiotensin II receptors Bradykinin receptors Kininogen,” vol. 88, pp. 77–88, 2012, doi: 10.1254/jphs.12R03CR.
[8] Y. Funakoshi and H. Omori, “Association between frequency of drinking alcohol and chronic kidney disease in men,” pp. 199–204, 2012, doi: 10.1007/s12199-011-0238-6.
[9] Z. V Varga and D. Ph, “Alcohol Misuse and Kidney Injury : Epidemiological Evidence and Potential Mechanisms,” pp. 283–288, 2012.
[10] C. A. Drummond et al., “Cigarette smoking and cardio-renal events in patients with atherosclerotic renal artery stenosis,” pp. 1–15, 2017.
[11] Y. Nagasawa, R. Yamamoto, H. Rakugi, and Y. Isaka, “Cigarette smoking and chronic kidney diseases,” no. December 2011, pp. 261–265, 2012, doi: 10.1038/hr.2011.205.
[12] A. Boon, A. C. Bulmer, J. S. Coombes, and R. G. Fassett, “Novel Therapeutics in Renal Diseases Circulating bilirubin and defense against kidney disease and cardiovascular mortality : mechanisms contributing to protection in clinical investigations,” vol. 2, 2014, doi: 10.1152/ajprenal.00039.2014.
[13] J. C. Jha, F. Ho, C. Dan, and K. Jandeleit-dahm, “A causal link between oxidative stress and inflammation in cardiovascular and renal complications of diabetes,” no. April, pp. 1811–1836, 2018.
[14] A. Toda, Y. Ishizaka, M. Tani, and M. Yamakado, “Hyperuricemia is a significant risk factor for the onset of chronic kidney disease,” Nephron - Clin. Pract., vol. 126, no. 1, pp. 33–38, 2014, doi: 10.1159/000355639.
[15] C. Giordano, O. Karasik, K. King-Morris, and A. Asmar, “Uric Acid as a Marker of Kidney Disease: Review of the Current Literature,” Dis. Markers, vol. 2015, 2015, doi: 10.1155/2015/382918.
[16] L. Gu, L. Huang, H. Wu, Q. Lou, and R. Bian, “Serum uric acid to creatinine ratio : A predictor of incident chronic kidney disease in type 2 diabetes mellitus patients with preserved kidney function,” no. 30, 2017, doi: 10.1177/1479164116680318.
[17] R. J. Johnson, T. Nakagawa, D. Jalal, L. G. Sánchez-Lozada, D. H. Kang, and E. Ritz, “Uric acid and chronic kidney disease: Which is chasing which?,” Nephrol. Dial. Transplant., vol. 28, no. 9, pp. 2221–2228, 2013, doi: 10.1093/ndt/gft029.
[18] Y. Ohta, T. Tsuchihashi, K. Kiyohara, and H. Oniki, “Increased uric acid promotes decline of the renal function in hypertensive patients: A 10-year observational study,” Intern. Med., vol. 52, no. 13, pp. 1467–1472, 2013, doi: 10.2169/internalmedicine.52.0141.
[19] M. Dennis et al., “PHYSIOLOGY IN MEDICINE : A SERIES OF ARTICLES LINKING MEDICINE WITH SCIENCE Review Pathogenesis of Gout,” Ann. Intern. Med., vol. 143, no. 7, pp. 499–516, 2005, [Online]. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3117776&tool=pmcentrez&rendertype=abstract.
[20] H. Guan et al., “Efficacy of different urinary uric acid indicators in patients with chronic kidney disease,” pp. 1–9, 2020.
[21] N. Boudville et al., “Effects of Allopurinol on the Progression of Chronic Kidney Disease,” pp. 2504–2513, 2020, doi: 10.1056/NEJMoa1915833.
[22] N. Aiumtrakul, P. Wiputhanuphongs, and O. Supasyndh, “Hyperuricemia and Impaired Renal Function : A Prospective Cohort Study,” pp. 210–218, 2021, doi: 10.1159/000511196.
[23] N. Miyatake, K. Shikata, H. Makino, and T. Numata, “Decreasing serum uric acid levels are associated with improving estimated glomerular filtration rate (eGFR) in Japanese women,” vol. 2013, no. May, pp. 40–43, 2013.
[24] S. Sedaghat et al., “Serum Uric Acid and Chronic Kidney Disease : The Role of Hypertension,” vol. 8, no. 11, pp. 1–8, 2013, doi: 10.1371/journal.pone.0076827.
[25] I. Galán et al., “Original article Hyperuricemia is associated with progression of chronic kidney disease in patients with reduced functioning kidney mass,” vol. 8, no. 1, pp. 73–78, 2017, doi: 10.1016/j.nefro.2017.04.006.
[26] “U.S. Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States | Michigan Medicine.” [Online]. Available: https://www.uofmhealth.org/news/archive/201911/us-renal-data-system-2019-annual-data-report-epidemiology.
[27] V. Hall, R. W. Thomsen, O. Henriksen, and N. Lohse, “Diabetes in Sub Saharan Africa 1999-2011 : Epidemiology and public health implications. a systematic review,” 2011.
[28] P. Delanaye, E. Cavalier, and H. Pottel, “Serum Creatinine: Not So Simple!,” Nephron, vol. 136, no. 4, pp. 302–308, 2017, doi: 10.1159/000469669.
[29] A. Milik and E. Hrynkiewicz, “On Translation of LD, IL and SFC Given According to IEC-61131 for Hardware Synthesis of Reconfigurable Logic Controller,” no. Ld, pp. 4477–4483, 2014.
[30] T. Fiseha, M. K. Ahmed, and T. Yemane, “Chronic kidney disease and underdiagnosis of renal insufficiency among diabetic patients attending a hospital in Southern Ethiopia,” no. December, 2014, doi: 10.1186/1471-2369-15-198.
[31] S. Study, A. T. Jigjiga, and K. G. Hospital, “ADDIS ABBABA UNIVERSITY CHOLEGE OF HEALTH SCEINCES SCHOOL OF GRADUATE STUDIES DEPARTMENT OF MEDICAL BIOCHEMISTRY ESTIMATION OF SERUM HIGH SENSITIVITY C - REACTIVE PROTEIN AND,” 2018.
[32] S. S. Han, K. Y. Na, D. Chae, Y. S. Kim, S. Kim, and H. J. Chin, “High Serum Bilirubin Is Associated with the Reduced Risk of Diabetes Mellitus and Diabetic Nephropathy,” pp. 133–140, 2010, doi: 10.1620/tjem.221.133.
[33] A. L. Ammirati, “Chronic Kidney Disease,” vol. 66, no. Suppl 1, 2020.
[34] R. Barata, F. Cardoso, and T. A. Pereira, “Hyperuricemia in Chronic Kidney Disease : a role yet to be explained,” vol. 34, no. March, pp. 30–35, 2020.
[35] H. Akasaka et al., “Original Article The impact of elevation of serum uric acid level on the natural history of glomerular fi ltration rate (GFR) and its sex difference,” pp. 1–8, 2014, doi: 10.1093/ndt/gfu197.
[36] K. Kritmetapak, S. Charoensri, R. Thaopanya, and C. Pongchaiyakul, “Elevated Serum Uric Acid is Associated with Rapid Decline in Kidney Function : A 10-Year Follow-Up Study,” 2020.
[37] W. X. Chang et al., “Uric Acid in the Follow-Up Determines 30% Decline in Estimated GFR Over 2 Years : a Propensity Score Analysis,” vol. 8605, pp. 1053–1067, 2017, doi: 10.1159/000485593.
[38] S. Kubo et al., “Higher serum uric acid level is inversely associated with renal function assessed by cystatin C in a Japanese general population without chronic kidney disease : the KOBE study,” pp. 1–8, 2019.
[39] J. J. Lee et al., “Relationship between uric acid and blood pressure in different age groups,” Clin. Hypertens., pp. 1–7, 2015, doi: 10.1186/s40885-015-0022-9.
[40] N. Ali, S. Mahmood, F. Islam, S. Rahman, and T. Haque, “Relationship between serum uric acid and hypertension : a cross- sectional study in Bangladeshi adults,” no. June, pp. 1–7, 2019, doi: 10.1038/s41598-019-45680-4.
[41] L. Gu, L. Huang, H. Wu, Q. Lou, and R. Bian, “Serum uric acid to creatinine ratio: A predictor of incident chronic kidney disease in type 2 diabetes mellitus patients with preserved kidney function,” Diabetes Vasc. Dis. Res., vol. 14, no. 3, pp. 221–225, 2017, doi: 10.1177/1479164116680318.
Cite This Article
  • APA Style

    Fikadu Seyoum Tola, Belay Zawdie, Maekel Belay. (2023). Evaluation of Uric Acid and Its Correlation with Decline in Estimated Glomerular Filtration Rate among the Chronic Kidney Disease Patients. European Journal of Clinical and Biomedical Sciences, 8(6), 84-91. https://doi.org/10.11648/j.ejcbs.20220806.12

    Copy | Download

    ACS Style

    Fikadu Seyoum Tola; Belay Zawdie; Maekel Belay. Evaluation of Uric Acid and Its Correlation with Decline in Estimated Glomerular Filtration Rate among the Chronic Kidney Disease Patients. Eur. J. Clin. Biomed. Sci. 2023, 8(6), 84-91. doi: 10.11648/j.ejcbs.20220806.12

    Copy | Download

    AMA Style

    Fikadu Seyoum Tola, Belay Zawdie, Maekel Belay. Evaluation of Uric Acid and Its Correlation with Decline in Estimated Glomerular Filtration Rate among the Chronic Kidney Disease Patients. Eur J Clin Biomed Sci. 2023;8(6):84-91. doi: 10.11648/j.ejcbs.20220806.12

    Copy | Download

  • @article{10.11648/j.ejcbs.20220806.12,
      author = {Fikadu Seyoum Tola and Belay Zawdie and Maekel Belay},
      title = {Evaluation of Uric Acid and Its Correlation with Decline in Estimated Glomerular Filtration Rate among the Chronic Kidney Disease Patients},
      journal = {European Journal of Clinical and Biomedical Sciences},
      volume = {8},
      number = {6},
      pages = {84-91},
      doi = {10.11648/j.ejcbs.20220806.12},
      url = {https://doi.org/10.11648/j.ejcbs.20220806.12},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ejcbs.20220806.12},
      abstract = {Chronic kidney disease is one of the most serious public health burdens globally, with significant morbidity, mortality, and compromise patient life expectancy. Many sub-Saharan African countries face double-burden challenges in the treating of chronic kidney disease and its associated complications. The current study aims to evaluate serum uric acid, and its correlation with estimated glomerular filtration rate as well as other risk factors among the chronic kidney disease patients on follow-up at renal clinic of Jimma University specialized referral hospital. An Institution-based cross-sectional study was conducted at Jimma University referral from August 6, 2022, to November 13, 2022. A consecutive sampling technique was employed to recruit the study participants into the current study. Data were collected using interviewer-based structured questionnaires and patient’s record reviews. The collected data were analyzed by SPSS version 25.0. Pearson’s correlation analyses was used to check the correlation between estimated glomerular filtration rate and uric acid. Univariate and multivariate linear regression model was used to test predictors of serum uric acid in the study participants. The total study participants were 140 individuals. Subjects included (54.3% [n=76]) men and (45.7% [n=64]) women, respectively. The mean (SD) age of study subjects was 51.04±9.02 years. The mean value of serum uric acid was 7.2±2.1mg/dl whereas the mean of estimated glomerular filtration rate (eGFR) was 54.2±31 mL/min/1.73m2. Furthermore, the mean values of serum creatinine and blood urea nitrogen among participants in this study were 3.2±1.4 and 67.8±35.8 mg/dL respectively. In the current study, estimated glomerular filtration rate (eGFR) value was negatively correlated (r=-0.912, P<0.001) with uric acid. However, systolic blood pressure was positively correlated (r=0.584, P<0.001) with uric acid. Moreover, the eGFR value was negatively associated (β=-0.060, P=<0.001) with uric acid among study participants. Based on the current study finding, an increase in serum uric acid was associated with a decrease in eGFR value. Increased serum uric acid, increased body mass index and high blood pressure are independent risk factors for disease progression in patients with CKD.},
     year = {2023}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Evaluation of Uric Acid and Its Correlation with Decline in Estimated Glomerular Filtration Rate among the Chronic Kidney Disease Patients
    AU  - Fikadu Seyoum Tola
    AU  - Belay Zawdie
    AU  - Maekel Belay
    Y1  - 2023/01/31
    PY  - 2023
    N1  - https://doi.org/10.11648/j.ejcbs.20220806.12
    DO  - 10.11648/j.ejcbs.20220806.12
    T2  - European Journal of Clinical and Biomedical Sciences
    JF  - European Journal of Clinical and Biomedical Sciences
    JO  - European Journal of Clinical and Biomedical Sciences
    SP  - 84
    EP  - 91
    PB  - Science Publishing Group
    SN  - 2575-5005
    UR  - https://doi.org/10.11648/j.ejcbs.20220806.12
    AB  - Chronic kidney disease is one of the most serious public health burdens globally, with significant morbidity, mortality, and compromise patient life expectancy. Many sub-Saharan African countries face double-burden challenges in the treating of chronic kidney disease and its associated complications. The current study aims to evaluate serum uric acid, and its correlation with estimated glomerular filtration rate as well as other risk factors among the chronic kidney disease patients on follow-up at renal clinic of Jimma University specialized referral hospital. An Institution-based cross-sectional study was conducted at Jimma University referral from August 6, 2022, to November 13, 2022. A consecutive sampling technique was employed to recruit the study participants into the current study. Data were collected using interviewer-based structured questionnaires and patient’s record reviews. The collected data were analyzed by SPSS version 25.0. Pearson’s correlation analyses was used to check the correlation between estimated glomerular filtration rate and uric acid. Univariate and multivariate linear regression model was used to test predictors of serum uric acid in the study participants. The total study participants were 140 individuals. Subjects included (54.3% [n=76]) men and (45.7% [n=64]) women, respectively. The mean (SD) age of study subjects was 51.04±9.02 years. The mean value of serum uric acid was 7.2±2.1mg/dl whereas the mean of estimated glomerular filtration rate (eGFR) was 54.2±31 mL/min/1.73m2. Furthermore, the mean values of serum creatinine and blood urea nitrogen among participants in this study were 3.2±1.4 and 67.8±35.8 mg/dL respectively. In the current study, estimated glomerular filtration rate (eGFR) value was negatively correlated (r=-0.912, P<0.001) with uric acid. However, systolic blood pressure was positively correlated (r=0.584, P<0.001) with uric acid. Moreover, the eGFR value was negatively associated (β=-0.060, P=<0.001) with uric acid among study participants. Based on the current study finding, an increase in serum uric acid was associated with a decrease in eGFR value. Increased serum uric acid, increased body mass index and high blood pressure are independent risk factors for disease progression in patients with CKD.
    VL  - 8
    IS  - 6
    ER  - 

    Copy | Download

Author Information
  • Medical Biochemistry Department, College of medicine and health Sciences, Ambo University, Addis Ababa, Ethiopia

  • Departments of Biomedical Sciences, Institute of Health Science, Jimma University, Addis Ababa, Ethiopia

  • Jimma University Specialized Referral Hospital, Jimma University, Addis Ababa, Ethiopia

  • Sections